The PDZ Protein GIPC Regulates Trafficking of the LPA1 Receptor from APPL Signaling Endosomes and Attenuates the Cell's Response to LPA

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Varsano, Tal ^a   Taupin, Vanessa ^a   Guo, Lixia ^a   Baterina, Oscar Y ^a   Farquhar, Marilyn G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAIP INTERACTING PROTEIN C TERMINUS; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; MYOSIN VI; PDZ PROTEIN; PROTEIN APPL; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; PDZ DOMAIN; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 84869053308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049227     Document Type: Article

References (53)

1. Liu S, Murph M, Panupinthu N, Mills GB, (2009) ATX-LPA receptor axis in inflammation and cancer. Cell Cycle 8: 3695-701.
2. Noguchi K, Herr D, Mutoh T, Chun J, (2009) Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9: 15-23.
3. Lin FT, Lai YJ, (2008) Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions. Biochim Biophys Acta 1781: 558-62.
4. Ishii S, Noguchi K, Yanagida K, (2009) Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 89: 57-65.
5. Liu TF, Kandala G, Setaluri V, (2001) PDZ domain protein GIPC interacts with the cytoplasmic tail of melanosomal membrane protein gp75 (tyrosinase-related protein-1). J Biol Chem 276: 35768-77.
6. Wang LH, Kalb RG, Strittmatter SM, (1999) A PDZ protein regulates the distribution of the transmembrane semaphorin, M-SemF. J Biol Chem 274: 14137-46.
7. De Vries L, Lou X, Zhao G, Zheng B, Farquhar MG, (1998) GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP. Proc Natl Acad Sci U S A 95: 12340-5.
8. Chittenden TW, Claes F, Lanahan AA, Autiero M, Palac RT, et al. (2006) Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 10: 783-95.
9. Choi JS, Paek AR, Kim SY, You HJ, (2010) GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling. Cancer Lett 294: 254-63.
10. Lou X, Yano H, Lee F, Chao MV, Farquhar MG, (2001) GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell 12: 615-27.
11. Varsano T, Dong MQ, Niesman I, Gacula H, Lou X, et al. (2006) GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol Cell Biol 26: 8942-52.
12. Naccache SN, Hasson T, Horowitz A, (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. Proc Natl Acad Sci U S A 103: 12735-40.
13. Lin DC, Quevedo C, Brewer NE, Bell A, Testa JR, et al. (2006) APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol Cell Biol 26: 8928-41.
14. Schenck A, Goto-Silva L, Collinet C, Rhinn M, Giner A, et al. (2008) The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133: 486-97.
15. Tan Y, You H, Wu C, Altomare DA, Testa JR, (2010) Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts. J Biol Chem 285: 6377-89.
16. Zoncu R, Perera RM, Balkin DM, Pirruccello M, Toomre D, et al. (2009) A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136: 1110-21.
17. Lanahan AA, Hermans K, Claes F, Kerley-Hamilton JS, Zhuang ZW, et al. (2010) VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell 18: 713-24.
18. Hirakawa T, Galet C, Kishi M, Ascoli M, (2003) GIPC binds to the human lutropin receptor (hLHR) through an unusual PDZ domain binding motif, and it regulates the sorting of the internalized human choriogonadotropin and the density of cell surface hLHR. J Biol Chem 278: 49348-57.
19. Jeanneteau F, Diaz J, Sokoloff P, Griffon N, (2004) Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol Biol Cell 15: 696-705.
20. Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H, (2003) Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway. J Cell Sci 116: 1969-80.
21. Urs NM, Kowalczyk AP, Radhakrishna H, (2008) Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA1 receptor. J Biol Chem 283: 5249-57.
22. Urs NM, Jones KT, Salo PD, Severin JE, Trejo J, et al. (2005) A requirement for membrane cholesterol in the beta-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors. J Cell Sci 118: 5291-304.
23. Ishii I, Contos JJ, Fukushima N, Chun J, (2000) Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 58: 895-902.
24. Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, et al. (1999) Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase Akt2. Oncogene 18: 4891-8.
25. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, et al. (1998) CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 140: 961-72.
26. Akiyama SK, (2002) Functional analysis of cell adhesion: quantitation of cell-matrix attachment. Methods Cell Biol 69: 281-96.
27. Alderton F, Sambi B, Tate R, Pyne NJ, Pyne S, (2001) Assessment of agonism at G-protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cells. Br J Pharmacol 134: 6-9.
28. De Vries L, Mousli M, Wurmser A, Farquhar MG, (1995) GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad Sci U S A 92: 11916-20.
29. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, et al. (2003) Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 64: 994-1005.
30. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, et al. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279: 17634-9.
31. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, et al. (2003) Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63: 1706-11.
32. Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, et al. (2004) Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem 279: 6595-605.
33. Murph MM, Nguyen GH, Radhakrishna H, Mills GB, (2008) Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation. Biochim Biophys Acta 1781: 547-57.
34. Yano H, Ninan I, Zhang H, Milner TA, Arancio O, et al. (2006) BDNF-mediated neurotransmission relies upon a myosin VI motor complex. Nat Neurosci 9: 1009-18.
35. Yamada T, Yano S, Ogino H, Ikuta K, Kakiuchi S, et al. (2008) Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2. Cancer Sci 99: 1603-10.
36. Muders MH, Dutta SK, Wang L, Lau JS, Bhattacharya R, et al. (2006) Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res 66: 10264-8.
37. Lee NY, Ray B, How T, Blobe GC, (2008) Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 283: 32527-33.
38. Gao Y, Li M, Chen W, Simons M, (2000) Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol 184: 373-9.
39. Weiner JA, Chun J, (1999) Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc Natl Acad Sci U S A 96: 5233-8.
40. Contos JJ, Ishii I, Chun J, (2000) Lysophosphatidic acid receptors. Mol Pharmacol 58: 1188-96.
41. Kingsbury MA, Rehen SK, Contos JJ, Higgins CM, Chun J, (2003) Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat Neurosci 6: 1292-9.
42. Hu LA, Chen W, Martin NP, Whalen EJ, Premont RT, et al. (2003) GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation. J Biol Chem 278: 26295-301.
43. Li C, Dandridge KS, Di A, Marrs KL, Harris EL, et al. (2005) Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med 202: 975-86.
44. Zhang H, Wang D, Sun H, Hall RA, Yun CC, (2007) MAGI-3 regulates LPA-induced activation of Erk and RhoA. Cell Signal 19: 261-8.
45. Yamada T, Ohoka Y, Kogo M, Inagaki S, (2005) Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs). J Biol Chem 280: 19358-63.
46. Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, et al. (2008) A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 1783: 748-59.
47. Chial HJ, Wu R, Ustach CV, McPhail LC, Mobley WC, et al. (2008) Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides. Traffic 9: 215-29.
48. Dance AL, Miller M, Seragaki S, Aryal P, White B, et al. (2004) Regulation of myosin-VI targeting to endocytic compartments. Traffic 5: 798-813.
49. Reed BC, Cefalu C, Bellaire BH, Cardelli JA, Louis T, et al. (2005) GLUT1CBP(TIP2/GIPC1) interactions with GLUT1 and myosin VI: evidence supporting an adapter function for GLUT1CBP. Mol Biol Cell 16: 4183-201.
50. Thomas RM, Nechamen CA, Mazurkiewicz JE, Ulloa-Aguirre A, Dias JA (2011) The Adapter Protein APPL1 Links FSH Receptor to Inositol 1,4,5-Trisphosphate Production and Is Implicated in Intracellular Ca2+ Mobilization. Endocrinology.
51. Blobe GC, Liu X, Fang SJ, How T, Lodish HF, (2001) A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 276: 39608-17.
52. Gotthardt M, Trommsdorff M, Nevitt MF, Shelton J, Richardson JA, et al. (2000) Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 275: 25616-24.
53. Lee JD, Hempel N, Lee NY, Blobe GC, (2010) The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling. Carcinogenesis 31: 175-83.